Search clinical trials for: Non -small cell lung cancer [NSCLC]
Total 184825 results
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMetastatic or Incurable Non-small Cell Lung Cancer | Relapsed, Refractory MelanomaUnited States
-
Maastricht UniversityUniversity of California, San Francisco; Centre Hospitalier Universitaire de... and other collaboratorsUnknownDetection | SegmentationNetherlands
-
Bristol-Myers SquibbNot yet recruitingNon-small Cell Lung Cancer (NSCLC)United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.UnknownNon Small Cell LungChina
-
Obsidian Therapeutics, Inc.RecruitingMelanoma | Lung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Metastatic Melanoma | Metastatic Non Small Cell Lung Cancer | Tumor SkinUnited States
-
University Hospital, RouenCompletedNon Small Cell Lung CancerFrance
-
Nir PeledNot yet recruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | Immune Checkpoint InhibitorIsrael
-
AVAX TechnologiesTerminatedNon-Small Cell Lung Cancer - Completely ResectableUnited States
-
Tu DanIncyte CorporationRecruiting
-
Ethicon Endo-Surgery (Europe) GmbHCompleted
-
Medical University of ViennaUnknownNon Small Cell Lung CancerAustria
-
Centre Oscar LambretUniversity Hospital, LilleTerminated
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Small Cell Lung Cancer | Prostate Cancer | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamousUnited States, Korea, Republic of, Italy, United Kingdom, Australia, Taiwan
-
PfizerCompletedNon-small Cell Lung CancerLebanon, Egypt, Morocco, Saudi Arabia, United Arab Emirates
-
The First Affiliated Hospital of Guangzhou Medical...Not yet recruitingNon-Small Cell Lung Cancer Stage IIIAChina
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonNot yet recruitingCancer | Diagnosis | Resistant Cancer | Response, Acute Phase
-
Gruppo Oncologico Italiano di Ricerca ClinicaIqvia Pty Ltd; AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations... and other collaboratorsCompletedNon-Small Cell Lung CancerItaly
-
National Taiwan University HospitalUnknown
-
University Hospital, MontpellierRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueAmgenActive, not recruitingNsclc | KRAS P.G12CFrance
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaSpain, Japan, Korea, Republic of, Taiwan, Netherlands, United States, Italy, Canada, Singapore
-
Xiaorong DongUnknownHealthy Subjects | NSCLC Stage IV | NSCLC, Stage III | NSCLC, Stage I | NSCLC, Stage IIChina
-
R-PharmCompleted
-
Fundación GECPActive, not recruitingNSCLC | Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIBSpain
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Shanghai Chest HospitalThe Affiliated Hospital of Qingdao University; Zhejiang University; Anhui Provincial...RecruitingNSCLC Stage IV | NSCLC Stage IIIB | NSCLC Stage IIICChina
-
The First Affiliated Hospital of Guangzhou Medical...RecruitingNSCLC, Stage III | NSCLC, Stage I | NSCLC, Stage IIChina
-
Guangdong Association of Clinical TrialsGuangdong Provincial People's HospitalRecruitingSmall-cell Lung CancerChina
-
Fujian Cancer HospitalNot yet recruiting
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Shandong Cancer Hospital and InstituteUnknown
-
Peking Union Medical CollegeRecruitingNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, RecurrentChina
-
AstraZenecaCompletedNewly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung CancerGermany
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Spanish Lung Cancer GroupCompleted
-
Hanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Beijing Chest HospitalUnknown
-
Sichuan Cancer Hospital and Research InstituteRecruitingNon-small Cell Lung Cancer MetastaticChina
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer | EGFR Gene MutationChina
-
Veeda OncologyBristol-Myers SquibbCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Tianjin Medical University Cancer Institute and...CompletedNon Small Cell Lung CancerChina
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Shanghai Kechow Pharma, Inc.Terminated
-
Jun Zhang, MD, PhDUniversity of Iowa; University of KentuckyRecruitingNSCLC Stage IV | NSCLC Stage IIIBUnited States
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.TerminatedNSCLC Stage IV | NSCLC, Stage IIICUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting